{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:04:33Z","timestamp":1777413873392,"version":"3.51.4"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Colorectal cancer (CRC) is a common malignant tumor that affects the large bowel or the rectum. Cuproptosis, recently discovered programmed cell death process, may play an important role in CRC tumorigenesis. Long non-coding RNAs (lncRNAs) can alter the proliferation of colorectal cancer cells through the control and activation of gene expression. To date, cuproptosis-related lncRNAs, have not been investigated as potential predictive biomarkers in colorectal cancer.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The mRNA and lncRNA expression data of colorectal cancer were gathered from The Tumor Genome Atlas (TCGA) database, and Pearson correlation analysis and univariate Cox regression analysis were used to identify the lncRNAs with differential prognosis. Colorectal cancer was classified using consistent clustering, and the clinical significance of different types, tumor heterogeneity, and immune microenvironment differences was investigated. The differential lncRNAs were further screened using LASSO regression to develop a risk scoring model, which was then paired with clinicopathological variables to create a nomogram. Finally, the copy number changes in the high-risk and low-risk groups were compared.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Two clusters were formed based on the 28 prognostic cuproptosis-related lncRNAs, and the prognosis of cluster 2 was found to be significantly lower than that of cluster 1. Cluster 1 showed increased immune cell infiltration and immunological score, as well as strong enrichment of immune checkpoint genes. Next, LASSO regression was used to select 11 distinctive lncRNAs, and a risk score model was constructed using the training set to distinguish between high and low-risk groups. Patients in the high-risk group had a lower survival rate than those in the low-risk group, and both the test set and the total set produced consistent results. The AUC value of the ROC curve revealed the scoring model\u2019s efficacy in predicting long-term OS in patients. Moreover, the model could be used as an independent predictor when combined with a multivariate analysis of clinicopathological features, and our nomogram could be used intuitively to predict prognosis.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Collectively, we developed a risk model using 11 differential lncRNAs and demonstrated that the model has predictive value as well as clinical and therapeutic implications for predicting prognosis in CRC patients.<\/jats:p>","DOI":"10.3389\/fgene.2022.969845","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T09:16:24Z","timestamp":1661764584000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Dong","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-nan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-yu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-hai","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1046\/j.1365-2168.1998.00601.x","article-title":"Effect of the introduction of total mesorectal excision for the treatment of rectal cancer.","volume":"85","author":"Carlsen","year":"1998","journal-title":"Br. J. Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1038\/s41388-021-01972-6","article-title":"Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer","volume":"40","author":"Cen","year":"2021","journal-title":"Oncogene"},{"key":"B3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s10528-020-10017-8","article-title":"LncRNA FTX promotes colorectal cancer cells migration and invasion by miRNA-590-5p\/RBPJ Axis.","volume":"59","author":"Chen","year":"2021","journal-title":"Biochem. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jso.21864","article-title":"Predictors of cure after hepatic resection of colorectal liver metastases: an analysis of actual 5- and 10-year survivors","volume":"103","author":"Chua","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijsu.2016.09.097","article-title":"The mesorectum and mesocolon - making sense of words.","volume":"36","author":"Dattani","year":"2016","journal-title":"Int. J. Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/ijms22041882","article-title":"PRKAR1B-AS2 long noncoding RNA promotes tumorigenesis, survival, and chemoresistance via the PI3K\/AKT\/mTOR pathway","volume":"22","author":"Elsayed","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? [J]","volume":"69","author":"Heald","year":"1982","journal-title":"Br. J. Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1463-1318.2008.01735.x","article-title":"Standardized surgery for colonic cancer: Complete mesocolic excision and central ligation--technical notes and outcome.","volume":"11","author":"Hohenberger","year":"2009","journal-title":"Colorectal Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"641891","DOI":"10.3389\/fcell.2021.641891","article-title":"Integrated characterization of lncRNA-immune interactions in prostate cancer [J]","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.abo3959","article-title":"Copper-induced cell death.","volume":"375","author":"Kahlson","year":"2022","journal-title":"Sci. (New York, NY)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.bbrc.2018.07.120","article-title":"LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p\/KLF10\/PTEN\/PI3K\/AKT cascade.","volume":"503","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"KRAS-IRF2 Axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJM200007203430301","article-title":"Use of colonoscopy to screen asymptomatic adults for colorectal cancer","volume":"343","author":"Lieberman","year":"2000","journal-title":"Veterans Aff. Coop. Study Group 380 J."},{"key":"B14","first-page":"11771","article-title":"Comprehensive study of a novel immune-related lncRNA for prognosis and drug treatment of cervical squamous cell carcinoma","volume":"13","author":"Liu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7931393","DOI":"10.1155\/2022\/7931393","article-title":"Prognosis risk model based on pyroptosis-related lncRNAs for bladder cancer [J]","volume":"2022","author":"Lu","year":"2022","journal-title":"Dis. Markers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"841814","DOI":"10.3389\/fmolb.2022.841814","article-title":"Selective targeting of cancer cells by copper ionophores: an overview.","volume":"9","author":"Oliveri","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"B21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000486721","article-title":"Tumor heterogeneity in colorectal cancer: what do we know so far?","volume":"85","author":"Sagaert","year":"2018","journal-title":"Pathobiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11743","DOI":"10.1038\/ncomms11743","article-title":"A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC","volume":"7","author":"Schell","year":"2016","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"A Cancer J. Clincians[J]"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jamaoto.2019.2427","article-title":"Prognostic value of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma","volume":"145","author":"Spector","year":"2019","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"B26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.suronc.2018.05.012","article-title":"Clinical significance and prognostic relevance of KRAS, braf, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: a systematic review of the current evidence","volume":"27","author":"Tsilimigras","year":"2018","journal-title":"Surg. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins.","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Sci. (New York, NY)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-019-1105-0","article-title":"LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4728947","DOI":"10.1155\/2020\/4728947","article-title":"An autophagy-related long noncoding RNA signature contributes to poor prognosis in colorectal cancer [J]","volume":"2020","author":"Wei","year":"2020","journal-title":"J. Oncol."},{"key":"B30","first-page":"762","article-title":"Profiles of immune infiltration in bladder cancer and its clinical significance: an integrative","volume":"17","author":"Wu","year":"2020","journal-title":"Genomic Anal. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1002\/ijc.32747","article-title":"Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer.","volume":"146","author":"Xu","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-020-1139-3","article-title":"CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer","volume":"19","author":"Yang","year":"2020","journal-title":"Mol. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1002\/ctm2.155","article-title":"MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer","volume":"10","author":"Yang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.critrevonc.2016.11.005","article-title":"Treatments for colorectal liver metastases: a new focus on a familiar concept","volume":"108","author":"Zampino","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11098-022-01845-y","article-title":"Reconceptualizing solidarity as power from below.","volume":"2","author":"Zheng","year":"2022","journal-title":"Philos. Stud."},{"key":"B37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12920-020-0707-0","article-title":"Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma","volume":"13","author":"Zhong","year":"2020","journal-title":"BMC Med. Genomics"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.969845\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T09:16:29Z","timestamp":1661764589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.969845\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":37,"alternative-id":["10.3389\/fgene.2022.969845"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.969845","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"article-number":"969845"}}